Walleye Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.79M Sell
18,200
-13,800
-43% -$3.66M 0.03% 535
2026
Q1
$3.51M Buy
32,000
+8,800
+38% +$1.25M 0.01% 1038
2025
Q4
$3.86M Sell
23,200
-26,900
-54% -$4.5M 0.01% 1341
2025
Q3
$9.81M Buy
50,100
+10,700
+27% +$1.76M 0.04% 558
2025
Q2
$3.56M Sell
39,400
-12,400
-24% -$980K 0.01% 1098
2025
Q1
$3.09M Buy
51,800
+46,000
+793% +$4.26M 0.01% 1113
2024
Q4
$768K Buy
+5,800
New +$544K ﹤0.01% 2617

Other funds holding ALAB

Walleye Capital's ALAB Position: Q2 2026 in Review

Walleye Capital reduced its Astera Labs (ALAB) stake by 69% in Q2 2026, selling an estimated $5.31M and leaving 8,806 shares worth $4.25M. The position accounts for 0.02% of the portfolio, ranked #929.

Walleye Capital first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $19.8M in Q3 2025. 990 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Walleye Capital held 8,806 shares of Astera Labs worth $4.25M as of Q2 2026.
  • Walleye Capital sold 20,008 Astera Labs shares in Q2 2026, an estimated $5.31M.
  • Astera Labs made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #929 holding.
  • Walleye Capital first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • Walleye Capital's Astera Labs position peaked at $19.8M in Q3 2025.
  • 990 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.